Iterum Therapeutics
Price & Volume
Stats
See more52W Range | $0.80-$3.02 |
Market Cap | $37.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$254,000 |
Diluted EPS | -$1.26 |
News
See moreYahoo Finance • 19 days ago
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
Yahoo Finance • 3 months ago
Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • 3 months ago
Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025
Yahoo Finance • last year
Iterum Therapeutics Reports Third Quarter 2023 Financial Results
About
CEO | Mr. Corey N. Fishman |
Address | 3 Dublin Landings, Dublin, Ireland, D01 C4E0 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |
